Status:

COMPLETED

Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure

Lead Sponsor:

Novartis Pharmaceuticals

Conditions:

Hypertension

Eligibility:

All Genders

6-5 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of three doses of valsartan (0.25, 1.0, and 4.0 mg/kg) on mean sitting systolic blood pressure (MSSBP) and mean sitting diastolic blood...

Eligibility Criteria

Inclusion

  • Children aged 6 months - 5 years at Visit 1, with a documented history of hypertension
  • Must be able to swallow liquid formulation
  • Must be ≥ 6 kg or ≤ 40 kg at randomization
  • Must have documented history MSSBP (mean of 3 measurements) must be ≥ 95th percentile for age, gender and height, at randomization
  • If patients enter with uncontrolled BP they can remain on background antihypertensives with an unchanged dosing regimen
  • If patients have had a solid organ transplant more than 1 year ago they must be on stable doses of immunosuppressive therapy
  • Parent(s)/guardian(s) are able to follow verbal and/or written instructions in the local language

Exclusion

  • Patients with background ARB therapy
  • Patients demonstrating any clinically significant abnormalities or clinically noteworthy abnormal lab values (other than those relating to renal function)
  • AST/SGOT or ALT/SGPT \> 3 times the upper limit of the reference range
  • Glomerular filtration rate \< 30 mL/min/1.73m²
  • Serum potassium \> upper limit of the reference range
  • MSSBP ≥ 25% above the 95th percentile
  • Patients exhibiting clinically significant ECG abnormalities
  • Patients that have coarctation of the aorta with a gradient of ≥ 30 mm Hg, or renal artery stenosis
  • Other protocol-defined inclusion/exclusion criteria may apply

Key Trial Info

Start Date :

March 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT00435162

Start Date

March 1 2007

End Date

January 1 2009

Last Update

May 9 2011

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Sites in USA

USA, New Jersey, United States

2

Sites in Belgium

Belgium, Belgium

3

Sites in Brazil

Brazil, Brazil

4

Sites in France

Paris, France